Mass treatment of trachoma with azithromycin 1.5% eye drops in the Republic of Cameroon: Feasibility, tolerance and effectiveness

British Journal of Ophthalmology

Volumn 94, Issue 2, 2010, Pages 157-160

  Huguet, P ^a   Bella, L ^b   Einterz, E M ^c   Goldschmidt, P ^d   Bensaid, P ^e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Ministry of Health   (Cameroon)

^c Kolofata District Health Service   (Cameroon)

^d CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^e Ophtalmo Sans Frontières ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; EYE DROPS;

ABSENCE OF SIDE EFFECTS; ARTICLE; CAMEROON; CHILD; DISEASE CONTROL; DRUG EFFICACY; DRUG TOLERABILITY; EPIDEMIOLOGICAL DATA; FEASIBILITY STUDY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; TRACHOMA;

AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BLINDNESS; CAMEROON; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; MALE; NATIONAL HEALTH PROGRAMS; OPHTHALMIC SOLUTIONS; PROGRAM EVALUATION; SEX DISTRIBUTION; TRACHOMA; TREATMENT OUTCOME;

EID: 76149122150     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.161513     Document Type: Article

References (14)

1. Bensaid P, Huguet P, Goldschmidt P, et al. Epidemiological survey of trachoma in the Kolofata district, Far North Province, Cameroon. Rev Int Trach Pathol Ocul Trop Subtrop santé Publique 2007;84:79-103.
2. World Health Organization. The SAFE strategy. Preventing trachoma: a guide for environmental sanitation and improved hygiene. WHO/PBD/00.7Rev1. Geneva: World Health Organization, 2001.
3. World Health Organization. Report of the eighth meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma. Report of a WHO Working Group. WHO/ PBD/GET/04.2. Geneva: World Health Organization, 2004.
4. National Institute of Statistics. Third General Census of the population and households of Cameroon. Yaounde: National Institute of Statistics, 2005.
5. World Health Organization. Primary health care level management of trachoma. WHO/PBL 93.33. Geneva: World Health Organization, 1993.
6. Katz I, Zeger SL, Tielsch JM. Village and household clustering of xerophthalmia and trachoma. Int J Epidemiol 1988;17:86-9.
7. Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull Org Mond Santé 1987;65:477-83.
8. Cochran WG. Sampling techniques. 3rd edn. New York: Wiley, 1977.
9. World Health Organization. Report of the Second Global Scientific Meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma. Report of a WHO Working Group. WHO/PBD/GET/03.1. Geneva: World Health Organization, 2003.
10. Amza A. Résultats après trois années de mise en œuvre de la stratégie CHANCE dans la Région de Zinder au Niger. Rev Int Trach Pathol Ocul Trop Subtrop santé Publique 2006;83:103-14.
11. Bamani S. La lutte contre le trachome au Mali: forces et faiblesses. Rev Int Trach Pathol Ocul Trop Subtrop santé Publique 2006;83:114-27
12. Cochereau I, Goldschmidt P, Goepogui A, et al. Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial. Br J Ophthalmol 2007;91:667-72.
13. World Health Organization. Report of the first meeting of the WHO Alliance for the Global Elimination of Trachoma. WHO/PBL/GET/97.1. Geneva: World Health Organization, 1997.
14. Tabbara KF, Abu-el-Asrar A, al Omar O, et al. Single-dose azithromycin in treatment of trachoma. A randomized, controlled study. Ophthalmology 1996;10:828-46.